Form 8-K - Current report:
SEC Accession No. 0001193125-23-010643
Filing Date
2023-01-19
Accepted
2023-01-19 08:30:04
Documents
14
Period of Report
2023-01-19
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d457598d8k.htm   iXBRL 8-K 25457
2 EX-99.1 d457598dex991.htm EX-99.1 8101
6 GRAPHIC g457598dsp4a.jpg GRAPHIC 5208
  Complete submission text file 0001193125-23-010643.txt   169305

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA sybx-20230119.xsd EX-101.SCH 2860
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE sybx-20230119_lab.xml EX-101.LAB 18758
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sybx-20230119_pre.xml EX-101.PRE 11717
8 EXTRACTED XBRL INSTANCE DOCUMENT d457598d8k_htm.xml XML 3453
Mailing Address 301 BINNEY STREET SUITE 402 CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET SUITE 402 CAMBRIDGE MA 02142 617-401-9975
SYNLOGIC, INC. (Filer) CIK: 0001527599 (see all company filings)

EIN.: 261824804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37566 | Film No.: 23535989
SIC: 2834 Pharmaceutical Preparations